Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of human umbilical cord mesenchymal stem cell injection for interstitial lung disease
CTR20242448Phase 2Active
- Sponsor
- Life-Biotech
- Start
- Jul 2024
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell in interstitial lung disease (ILD), sponsored by Life-Biotech. Started Jul 2024; status: active.
02
Drugs
human umbilical cord mesenchymal stem cell
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on CTR20242448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242448.